Skip to main content
SpringerLink
Log in

Cancer Screening in the U.S. and Europe: Policies, Practices, and Trends in Cancer Incidence and Mortality

  • Chapter
  • First Online:
Applied Demography and Public Health

Part of the book series: Applied Demography Series ((ADS,volume 3))

Abstract

Population-based data are increasingly used to elucidate the burden of cancer worldwide. Incidence and mortality data from regional and national cancer registries should allow researchers to monitor trends and disparities in cancer occurrence, survival, and mortality in populations and subgroups of the population and to evaluate the effectiveness of screening for cancers amenable to early detection and treatment. Given that the primary purpose of screening is to reduce the number of deaths attributable to cancer, cancer mortality is assumed to be the most important indicator of the effectiveness of screening and the most basic measure of progress against cancer (Hakama et al. 2008; Jatoi and Miller 2003). In setting screening policy, the deaths saved by screening, however, must be weighed against any adverse effects of screening resulting from over identifying or over treating cases, as well as monetary costs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • American Cancer Society. (2009). Cancer prevention & early detection facts & figures 2009. Atlanta: American Cancer Society.

    Google Scholar 

  • Andriole, G., Crawford, E., Grubb, R., Buys, S., Chia, D., Church, T., et al. (2009). Mortality results from a randomized prostate-cancer screening trial. The New England Journal of Medicine, 360, 1310–1319.

    Article  Google Scholar 

  • Anees, B., Chagpar, M. D., & McMasters, K. M. (2007). Trends in mammography and clinical breast examination: A population-based study. Journal of Surgical Research, 140, 214–219.

    Article  Google Scholar 

  • Atkin, W. (2003). Options for screening for colorectal cancer. Scandinavian Journal of Gastroenterology, 38(Suppl 237), 13–16.

    Article  Google Scholar 

  • Atkin, W. S., Edwards, R., Kralj-Hans, I., Wooldrage, K., et al. (2010). Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: A multicenter randomized controlled trial. Lancet, 375, 1624–1633.

    Article  Google Scholar 

  • Baade, P. D., Coory, M. D., & Aitken, J. F. (2004). International trends in prostate-cancer mortality: The decrease is continuing and spreading. Cancer Causes & Control, 15, 237–241.

    Article  Google Scholar 

  • Bangma, C. H., Roemeling, S., & Schroder, F. H. (2007). Overdiagnosis and overtreatment of early detected prostate cancer. World Journal of Urology, 25(1), 3–9.

    Article  Google Scholar 

  • Benson, V. S., Patnick, J., Davies, A. K., Nadel, M. R., Smith, R. A., & Atkin, W. S. (2007). Colorectal cancer screening: A comparison of 35 initiatives in 17 countries. International Journal of Cancer, 122, 1357–1367.

    Article  Google Scholar 

  • Bentzen, S. M., Heeren, G., Cottier, B., Slotman, B., Glimelius, B., Lievens, Y., & van den Bogaert, W. (2005). Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: The ESTRO QUARTS project. Radiotherapy and Oncology, 75(3), 355–365.

    Article  Google Scholar 

  • Botha, J. L., Bray, F., Sankila, R., & Parkin, D. M. (2003). Breast cancer incidence and mortality trends in 16 European countries. European Journal of Cancer, 39(12), 1718–1729.

    Article  Google Scholar 

  • Bouchardy, C., Fioretta, G., Rapiti, E., Verkooijen, H. M., Rapin, C. H., Schmidlin, F., et al. (2008). Recent trends in prostate cancer mortality show a continuous decrease in several countries. International Journal of Cancer, 123(2), 421–429.

    Article  Google Scholar 

  • Boyle, P., & Brawley, O. W. (2009). Prostate cancer: Current evidence weighs against population screening. CA: A Cancer Journal for Clinicians, 59(4), 220–224.

    Article  Google Scholar 

  • Boyle, P., & Ferlay, J. (2005a). Mortality and survival in breast and colorectal cancer. Nature Clinical Practice Oncology, 2, 424–425.

    Article  Google Scholar 

  • Boyle, P., & Ferlay, J. (2005b). Cancer incidence and mortality in Europe, 2004. Annals of Oncology, 16(3), 481–488.

    Article  Google Scholar 

  • Brawley, O. W., Knopf, K., & Merrill, R. (1998). The epidemiology of prostate cancer part I: Descriptive epidemiology. Seminars in Urologic Oncology, 16, 187–192.

    Google Scholar 

  • Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J., et al. (1991). Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. The New England Journal of Medicine, 324(17), 1156–1161.

    Article  Google Scholar 

  • Centers for Disease Control and Prevention (CDC). (2011). Colorectal cancer screening – United States, 2002, 2004, 2006, and 2008. Morbidity and Mortality Weekly Report, 60(Suppl), 42–46.

    Google Scholar 

  • Chen, X., White, M. C., Peipens, L. A., & Seeff, L. C. (2008). Increase in screening for colorectal cancer in older Americans: Results from a National Survey. Journal of American Geriatrics Society, 56(8), 1511–1516.

    Article  Google Scholar 

  • Coleman, M. P., Quaresma, M., Berrino, F., Lutz, J. M., De Angelis, R., Capocaccia, R., et al. (2008). Cancer survival in five continents: A worldwide population-based study (CONCORD). The Lancet Oncology, 9(8), 730–756.

    Article  Google Scholar 

  • Collin, S. M., Martin, R. M., Metcalfe, C., Gunnell, D., Albertsen, P. C., Neal, D., et al. (2008). Prostate-cancer mortality in the USA and UK in 1975–2004: An ecological study. The Lancet Oncology, 9(5), 445–452.

    Article  Google Scholar 

  • Cookson, M. S. (2001). Prostate cancer: Screening and early detection. Cancer Control, 8(2), 133–140.

    Google Scholar 

  • Crimmins, E. M., Garcia, K., & Kim, J. K. (2010). Are international differences in health similar to international differences in life expectancy? In E. Crimmins, S. Preston, & B. Cohen (Eds.), International differences in mortality at older ages: Dimensions and sources. Washington, D.C.: The National Academies Press.

    Google Scholar 

  • Croswell, J. M., Kramer, B. S., Kreimer, A. R., Prorok, P. C., Xu, J. L., Baker, S. G., et al. (2009). Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Annals of Family Medicine, 7(3), 212–222.

    Article  Google Scholar 

  • Cutler, D. M. (2008). Are we finally winning the war on cancer? Journal of Economic Perspectives, 22(4), 3–26.

    Article  Google Scholar 

  • Draisma, G., Postma, R., Schröder, F. H., van der Kwast, T. H., & de Koning, H. J. (2006). Gleason score, age and screening: Modeling dedifferentiation in prostate cancer. International Journal of Cancer, 119(10), 2366–2371.

    Article  Google Scholar 

  • Duffy, S. W., Agbaje, O., Tabar, L., Vitak, B., Bjurstam, N., Björneld, L., et al. (2005). Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Research, 7, 258–265.

    Article  Google Scholar 

  • Duffy, S. W., Lynge, E., Jonsson, H., Ayyaz, S., & Olsen, A. H. (2008). Complexities in the estimation of overdiagnosis in breast cancer screening. British Journal of Cancer, 99(7), 1176–1178.

    Article  Google Scholar 

  • Ekeberg, Ø., Skjauff, H., & Kåresen, R. (2001). Screening for breast cancer is associated with a low degree of psychological distress. Breast, 10(1), 20–24.

    Article  Google Scholar 

  • Elmore, J. G., Barton, M. B., Moceri, V. M., Polk, S., Arena, P. J., & Fletcher, S. W. (1998). Ten-­year risk of false positive screening mammograms and clinical breast examinations. The New England Journal of Medicine, 338(16), 1089–1096.

    Article  Google Scholar 

  • Elmore, J. G., Armstrong, K., Lehman, C. D., & Fletcher, S. W. (2005). Screening for breast cancer. Journal of the American Medical Association, 293(10), 1245–1256.

    Article  Google Scholar 

  • Esserman, L., Shieh, Y., & Thompson, I. (2009). Rethinking screening for breast cancer and prostate cancer. Journal of the American Medical Association, 302(15), 1685–1692.

    Article  Google Scholar 

  • Etzioni, R., & Feuer, E. (2008). Studies of prostate-cancer mortality: Caution advised. The Lancet Oncology, 9(5), 407–409.

    Article  Google Scholar 

  • Etzioni, R., Legler, J. M., Feuer, E. J., et al. (1999). Cancer surveillance series; interpreting trends in prostate cancer – Part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. Journal of the National Cancer Institute, 91, 1033–1039.

    Article  Google Scholar 

  • Etzioni, R., Penson, D. F., Legler, J. M., di Tommaso, D., Boer, R., Gann, P. H., & Feuer, E. J. (2002). Overdiagnosis due to prostate-specific antigen screening: Lessons from U.S. prostate cancer incidence trends. Journal of the National Cancer Institute, 94(13), 981–990.

    Article  Google Scholar 

  • European Society of Medical Oncology (ESMO). (2006). Medical Oncology Status in Europe Survey (MOSES): Phase II. In R. Labianca (Ed.). Available online: http://www.esmo.org/fileadmin/media/pdf/surveys/MOSES.pdf

  • Farrow, D. C., Samet, J. M., & Hunt, W. C. (1996). Regional variation in survival following the diagnosis of cancer. Journal of Clinical Epidemiology, 49(8), 843–847.

    Article  Google Scholar 

  • Ferlay, J., Bray, F., Pisani, P., & Parkin, D. M. (2004). GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide (IARC Cancer Base No. 5 Version 2.0). Lyon: IARC Press. Available from: http://www-dep.iarc.fr

  • Ferlay, J., Parkin, D. M., Curado, M. P., Bray, F., Edwards, B., Shin, H.R., & Forman, D. (2010). Cancer incidence in five continents (Vols. I–IX: IARC CancerBase No. 9 [Internet]). Lyon: International Agency for Research on Cancer. Available from: http://ci5.iarc.fr

  • Galit, W., Green, M. S., & Lital, K. B. (2007). Routine screening mammography in women older than 74 years: A review of the available data. Maturitas, 57(2), 109–119.

    Article  Google Scholar 

  • Gatta, G., Capocaccia, R., Sant, M., et al. (2002). Understanding variations in colorectal cancer survival in Europe: A EUROCARE high-resolution study. Gut, 47, 533–538.

    Article  Google Scholar 

  • Glass, A. G., Lacey, J. V., Carreon, D., & Hoover, R. N. (2007). Breast cancer incidence, 1980–2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. Journal of the National Cancer Institute, 99, 1152–1161.

    Article  Google Scholar 

  • Goldberg, C. (2010, September 10). DIY mammogram math: 1 in 20,000 odds. CommonHealth. Available online: http://commonhealth.wbur.org/2010/09/diy-mammogram-math-1-in-20000-odds/

  • Hakama, M., Coleman, M., Alexe, D. M., & Auvinen, A. (2008). Cancer screening. In M. O. Coleman, D. M. Alexe, T. Albreht, & M. McKee (Eds.), Responding to the challenge of cancer in Europe. Slovenia: Institute of Public Health of the Republic of Slovenia.

    Google Scholar 

  • Hardcastle, J. D., Chamberlain, J. O., Robinson, M. H., Moss, S. M., Amar, S. S., Balfour, T. W., et al. (1996). Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet, 348(9040), 1472–1477.

    Article  Google Scholar 

  • Harewood, G. C., & Lieberman, D. A. (2004). Colonoscopy practice patterns since introduction of Medicare coverage for average-risk screening. Clinical Gastroenterology and Hepatology, 2, 72–77.

    Article  Google Scholar 

  • Harlan, L. C., Abrams, J., Warren, J. L., et al. (2002). Adjuvant therapy for breast cancer: Practice patterns of community physicians. Journal of Clinical Oncology, 20, 1809–1817.

    Article  Google Scholar 

  • Hass, G. P., Delongchamps, N. B., Jones, R. F., Chandan, V., Serio, A. M., Vickers, A. J., et al. (2007). Needle biopsies on autopsy prostates: Sensitivities of cancer detection based on true prevalence. Journal of the National Cancer Institute, 99, 1484–1489.

    Article  Google Scholar 

  • Hawkes, E. A., & Cunningham, D. (2010). Flexible sigmoidoscopy-valuable in colorectal cancer. Nature Reviews Clinical Oncology, 7(9), 488–490.

    Article  Google Scholar 

  • Holmström, B., Johansson, M., Bergh, A., Stenman, U. H., Hallmans, G., & Stattin, P. (2009). Prostate specific antigen for early detection of prostate cancer: Longitudinal study. British Medical Journal, 339, b3537.

    Article  Google Scholar 

  • Horner, M. J., Ries, L. A., Krapcho, M., et al. (Eds.). (2009). SEER cancer statistics review, 1975–2006. Bethesda: National Cancer Institute. Available online at: seer.cancer.gov/csr/1975_2006/

  • Horninger, W., Reissigl, A., Rogatsch, H., Volgger, H., Studen, M., Klocker, H., & Bartsch, G. (1999). Prostate cancer screening in Tyrol, Austria: Experience and results. European Urology, 35(5–6), 523–538.

    Article  Google Scholar 

  • Howard, D. H., Richardson, L. C., & Thorpe, K. E. (2009). Cancer screening and age in the United States and Europe. Health Affairs, 28(6), 1838–1847.

    Article  Google Scholar 

  • Hsing, A. W., Tsao, L., & Deves, S. S. (2000). International trends and patterns of prostate cancer incidence and mortality. International Journal of Cancer (Pred. Oncol.), 85, 60–67.

    Article  Google Scholar 

  • Humphrey, L. L., Helfand, M., Chan, B. K., & Woolf, S. H. (2002). Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 137(5(1)), 347–360.

    Google Scholar 

  • Jatoi, I., & Miller, A. B. (2003). Why is breast-cancer mortality declining? The Lancet Oncology, 4(4), 251–254.

    Article  Google Scholar 

  • Jemal, A., Ward, E., & Thun, M. (2010). Declining death rates reflect progress against cancer. PLoS One, 5(3), e9584.

    Article  Google Scholar 

  • Joinpoint Regression Program, Version 3.3. (2008, April). Statistical methodology and applications branch, Surveillance Research Program. Bethesda: National Cancer Institute.

    Google Scholar 

  • Jørgensen, K. J., & Gøtzsche, P. C. (2009). Overdiagnosis in publicly organized mammography screening programmes: Systematic review of incidence trends. British Medical Journal, 339, b2587.

    Article  Google Scholar 

  • Jørgensen, O. D., Kronborg, O., & Fenger, C. (2002). A randomized study of screening for colorectal cancer using faecal occult blood testing: Results after 13 years and seven biennial screening rounds. Gut, 50, 29–32.

    Article  Google Scholar 

  • Jørgensen, K. J., Zahl, P. H., & Gøtzsche, P. C. (2009). Overdiagnosis in organized mammography screening in Denmark. A comparative study. BMC Women's Health, 9, 36.

    Article  Google Scholar 

  • Karim-Kos, H. E., de Vries, E., Soerjomataram, I., Lemmens, V., Siesling, S., & Coebergh, J. W. (2008). Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality of 17 cancer sites since the 1990s. European Journal of Cancer, 44, 1345–1389.

    Article  Google Scholar 

  • Kronborg, O., Fenger, C., Olsen, J., Jørgensen, O. D., & Søndergaard, O. (1996). Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet, 348(9040), 1467–1471.

    Article  Google Scholar 

  • La Rochelle, J., & Amling, C. L. (2010). Prostate cancer screening: What we have learned from the PLCO and ERSPC trials. Current Urology Reports, 11(3), 198–201.

    Article  Google Scholar 

  • La Vecchia, C., Bosetti, C., Lucchini, F., Bertuccio, E., Negri, E., Boyle, P., & Levi, F. (2010). Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Annals of Oncology, 21, 1323–1360.

    Article  Google Scholar 

  • Lampic, C., Thurfjell, E., Bergh, J., & Sjödén, P. O. (2001). Short- and long-term anxiety and depression in women recalled after breast cancer screening. European Journal of Cancer, 37(4), 463–469.

    Article  Google Scholar 

  • Lerman, C., Trock, B., Rimer, B. K., Boyce, A., Jepson, C., & Engstrom, P. F. (1991). Psychological and behavioral implications of abnormal mammograms. Annals of Internal Medicine, 114(8), 657–661.

    Article  Google Scholar 

  • Levi, F., Bosetti, C., Lucchini, F., Negri, E., & La Vecchia, C. (2005). Monitoring the decrease in breast cancer mortality in Europe. European Journal of Cancer Prevention, 14(6), 497–502.

    Article  Google Scholar 

  • Loeve, F., Brown, M. L., Boer, R., van Ballegooijen, M., van Oortmarssen, G. J., & Habbema, J. D. (2000). Endoscopic colorectal cancer screening: A cost-saving analysis. Journal of the National Cancer Institute, 92(7), 557–563.

    Article  Google Scholar 

  • Mandel, J. S., Church, T. R., Ederer, F., & Bond, J. H. (1999). Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. Journal of the National Cancer Institute, 91(5), 434–437.

    Article  Google Scholar 

  • Mariotto, A., Feuer, E., Harlan, L., et al. (2002). Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975–1999. Journal of the National Cancer Institute, 94, 1626–1634.

    Article  Google Scholar 

  • McCarthy, E. P., Burns, R. B., Freund, K. M., et al. (2000). Mammography use, breast cancer stage at diagnosis, and survival among older women. Journal of American Geriatrics Society, 48, 1226–1233.

    Google Scholar 

  • McPherson, C. P., Swenson, K. K., & Lee, M. W. (2002). The effects of mammographic detection and comorbidity on the survival of older women with breast cancer. Journal of American Geriatrics Society, 50, 1061–1068.

    Article  Google Scholar 

  • Meissner, H. I., Breen, N., Klabunde, C. N., & Vernon, S. W. (2006). Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiology, Biomarkers & Prevention, 15(2), 389–394.

    Article  Google Scholar 

  • Meng, M. V., Grossfeld, G. D., Sadetsky, N., et al. (2002). Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer. Urology, 60(3 Supp 1), 7–11.

    Article  Google Scholar 

  • Mettlin, C. (2000). Impact of screening on prostate cancer rates and trends. Microscopy Research and Technique, 51, 415–418.

    Article  Google Scholar 

  • Micheli, A., Coebergh, J. W., Mugno, E., et al. (2003). European health systems and cancer care. Annals of Oncology, 14(5), 41–60.

    Article  Google Scholar 

  • Miles, A., Cockburn, J., Smith, R. A., & Wardle, J. (2004). A perspective from countries using organized screening programs. Cancer, 101(5 Suppl), 1201–1213.

    Article  Google Scholar 

  • Nelson, H. D., Tyne, K., Bougatsos, C., Chan, B. K., & Humphrey, L. (2009). Screening for breast cancer: An update for the U.S. Preventative Services Task Force. Annals of Internal Medicine, 151(10), 727–737.

    Article  Google Scholar 

  • NHS Screening Programmes. (2006). Breast screening: Over 70? You are still entitled to breast screening. London: Department of Health.

    Google Scholar 

  • Nystrom, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjold, B., & Rutqvist, L. E. (2002). Long-term effects of mammography screening: Updated overview of the Swedish randomized trials. Lancet, 359, 909–919.

    Article  Google Scholar 

  • Olsen, A. H., Agbaje, O. F., Myles, J. P., Lynge, E., & Duffy, S. W. (2006). Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. The Breast Journal, 12, 338–342.

    Article  Google Scholar 

  • Organization for Economic Co-operation and Development. (2006). OECD health data 2006, from the OECD Internet subscription database. OECD 2006. Available from: http://www.oecd.org/health/healthdata

  • Paci, E., & Duffy, S. (2005). Overdiagnosis and overtreatment of breast cancer: Overdiagnosis and overtreatment in service screening. Breast Cancer Research, 7(6), 266–270.

    Article  Google Scholar 

  • Paci, E., Warwick, J., Falini, P., & Duffy, S. W. (2004). Overdiagnosis in screening: Is the increase in breast cancer incidence rates a cause for concern? Journal of Medical Screening, 11(1), 23–27.

    Article  Google Scholar 

  • Paci, E., Miccinesi, G., Puliti, D., Baldazzi, P., De Lisi, V., Falcini, F., et al. (2006). Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy. Breast Cancer Research, 8, R68.

    Article  Google Scholar 

  • Parkin, D. M., Bray, F. I., & Devesa, S. S. (2001). Cancer burden in the year 2000: The global picture. European Journal of Cancer, 37(suppl 8), S4–S66.

    Article  Google Scholar 

  • Patnick, J. (Ed.). (2009). NHS breast screening programme annual review 2009. NHS Cancer Screening Programs, 2009. Available from: http://www.camcerscreening.nhs.uk

  • Pinsky, P. F., Blacka, A., Kramer, B. S., Miller, A., Prorok, P. C., & Berg, C. (2010). Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial. Clinical Trials, 7(4), 303–311.

    Article  Google Scholar 

  • Pito, R., Boreham, J., Clarke, M., Davies, C., & Beral, V. (2000). UK and USA breast cancer Deaths down 25% in year 2000 at ages 20–69 years. Lancet, 355, 1822.

    Article  Google Scholar 

  • Postma, R., van Leenders, A. G., Roobol, M. J., Schröder, F. H., & van der Kwast, T. H. (2006). Tumour features in the control and screening arm of a randomized trial of prostate cancer. European Urology, 50(1), 70–75.

    Article  Google Scholar 

  • Potosky, A. L., Legler, J., Albertsen, P. C., et al. (2000). Health outcomes after prostatectomy or radiotherapy for prostate cancer: Results from the Prostate Cancer Outcomes Study. Journal of the National Cancer Institute, 92(19), 1582–1592.

    Article  Google Scholar 

  • Pox, C., Schmiegel, W., & Classen, M. (2007). Current status of screening colonoscopy in Europe and in the United States. Endoscopy, 39, 168–173.

    Article  Google Scholar 

  • Preston, S. H. (2009). Prostate-cancer screening. The New England Journal of Medicine, 361(2), 202–203.

    Article  Google Scholar 

  • Preston, S. H., & Ho, J. (2010). Low life expectancy in the United States: Is the health care system at fault? In E. Crimmins, S. Preston, & B. Cohen (Eds.), International differences in mortality at older ages: Dimensions and sources (p. 2010). Washington, D.C.: The National Academies Press.

    Google Scholar 

  • Prorok, P. C., Connor, R. J., & Baker, S. G. (1990). Statistical considerations in cancer screening programs. The Urologic Clinics of North America, 17(4), 699–708.

    Google Scholar 

  • Quanstrum, K. H., & Hayward, R. A. (2010). Lessons from mammography wars. The New England Journal of Medicine, 363(11), 1076–1079.

    Article  Google Scholar 

  • Quinn, M., & Babb, P. (2002). Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: International comparisons. BJU International, 90(2), 162–173.

    Article  Google Scholar 

  • Quinn, M. J., d’Onofrio, A., Møller, B., Black, R., Martinez-Garcia, C., Møller, H., et al. (2003). Cancer mortality trends in the EU and acceding countries up to 2015. Annals of Oncology, 14, 1148–1152.

    Article  Google Scholar 

  • Raaijmakers, R., Kirkels, W. J., Roobol, M. J., Wildhagen, M. F., & Schrder, F. H. (2002). Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology, 60(5), 826–830.

    Article  Google Scholar 

  • Rabeneck, L., Paszat, L. F., Saskin, R., & Stukel, T. A. (2010). Association between colonoscopy rates and colorectal cancer mortality. The American Journal of Gastroenterology, 105(7), 1627–1632.

    Article  Google Scholar 

  • Rietbergen, J. B., Hoedemaeker, R. H., Kruger, A. E., Kirkels, W. J., & Schroeder, F. H. (1999). The changing pattern of prostate cancer at the time of diagnosis: Characteristics of screen detected prostate cancer in a population based screening study. The Journal of Urology, 161, 1192–1198.

    Article  Google Scholar 

  • Rohde, V., Weidner, W., & Katalinic, A. (2009). Decrease in prostate cancer incidence and mortality in Germany – Effects of opportunistic PSA screening or more? Urologia Internationalis, 83, 134–140.

    Article  Google Scholar 

  • Rutqvist, L. E. (2006). Waiting times for cancer patients-a “slippery slope” in oncology. Acta Oncologica, 45, 121–123.

    Article  Google Scholar 

  • Sakr, W. A., Grignon, D. J., Crissman, J. D., Heilbrun, L. K., Cassin, B. J., Pontes, J. J., & Haas, G. P. (1994). High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic Adenocarcinoma between the ages of 20–69: An autopsy study of 249 cases. In Vivo, 8(3), 439–443.

    Google Scholar 

  • Sanchez-Chapado, M., Olmedilla, G., Cabeza, M., Donat, E., & Ruiz, A. (2003). Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: An autopsy study. The Prostate, 54, 238–247.

    Article  Google Scholar 

  • Sant, M. (2001). Differences in stage and therapy for breast cancer across Europe. International Journal of Cancer, 93, 894–901.

    Article  Google Scholar 

  • Schroder, F., Hugosson, J., Roobol, M., Tammela, T., Ciatto, S., Nelen, V., et al. (2009). Screening and prostate-cancer mortality in a randomized European study. The New England Journal of Medicine, 360, 1320–1328.

    Article  Google Scholar 

  • Segi, M. (1960). Cancer mortality for selected sites in 24 countries (1950–57). Sendai: University School of Public Health.

    Google Scholar 

  • Semiglazov, V. F., Manikhas, A. G., Moiseenko, V. M., Protsenko, S. A., Kharikova, R. S., Seleznev, I. K., et al. (2003). Results of a prospective randomized investigation [Russia (St.Petersburg)/WHO] to evaluate the significance of self-examination for the early detection of breast cancer. Voprosy Onkologii, 49(4), 434–441.

    Google Scholar 

  • Shapiro, S. (1994). Screening: Assessment of current studies. Cancer, 74(1Suppl), 231–238.

    Article  Google Scholar 

  • Shapiro, S., Coleman, E. A., Broeders, M., Codd, M., de Koning, H., Fracheboud, J., et al. (1998). Breast cancer screening programmes in 22 countries: Current policies, administration and guidelines. International Journal of Epidemiology, 27, 735–742.

    Article  Google Scholar 

  • Soos, G., Tsakiris, I., Szanto, J., Turzo, C., Hass, P. G., & Dezso, B. (2005). The prevalence of prostate carcinoma and its precursor in Hungary: An autopsy study. European Journal of Urology, 48, 739–744.

    Article  Google Scholar 

  • Stefanick, M. L. (2005). Estrogens and progestins: Background and history, trends in use, and guidelines and regines approved by the US food and drug administration. American Journal of Medicine, 118(12B), 64–73.

    Article  Google Scholar 

  • Stephenson, R. A. (1998). Population-based prostate cancer trends in the PSA era: Data from the Surveillance, Epidemiology, and the End Results (SEER) program. Monographs in Urology, 19, 3–19.

    Google Scholar 

  • Stock, C., & Brenner, H. (2010). Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: Evidence from the Survey of Health, Aging and Retirement in Europe (SHARE). Endoscopy, 42(7), 546–556.

    Article  Google Scholar 

  • Stock, C., Haug, U., & Brenner, H. (2010). Population-based prevalence estimates of history of colonoscopy or sigmoidoscopy: Review and analysis of recent trends. Gastrointestinal Endoscopy, 71(2), 366–381.

    Article  Google Scholar 

  • Tabar, L., Vitak, B., Yen, M. F., Chen, H. H., Smith, R. A., & Duffy, S. W. (2004). Number needed to screen: Lives saved over 20 years of follow-up in mammographic screening. Journal of Medical Screening, 11(3), 126–129.

    Article  Google Scholar 

  • Thomas, D. B., Gao, D. L., Self, S. G., Allison, C. J., Tao, Y., Mahloch, J., et al. (1997). Randomized trial of breast self-examination in Shanghai: Methodology and preliminary results. Journal of the National Cancer Institute, 89, 355–365.

    Article  Google Scholar 

  • Thompson, I. M., Pauler, D. K., Goodman, P. J., Tangen, C. M., Lucia, M. S., Parnes, H. L., et al. (2004). Prevalence of prostate cancer among men with a prostate-specific antigen level< or = 4.0 ng per milliliter. The New England Journal of Medicine, 350(22), 2239–2246.

    Article  Google Scholar 

  • Tyczynski, J. E., Plesko, I., Aareleid, T., Primic-Zakelj, M., Dalmas, M., Kurtinaitis, J., et al. (2004). Breast cancer mortality patterns and time trends in 10 new EU member states: Mortality declining in young women, but still increasing in the elderly. International Journal of Cancer, 112(6), 1056–1064.

    Article  Google Scholar 

  • U.S. Preventative Services Task Force. (2008a). Screening for colorectal cancer: U.S. Preventative Services Task Force recommendation statement. Annals of Internal Medicine, 149(9), 627–637.

    Article  Google Scholar 

  • U.S. Preventative Services Task Force. (2008b). Screening for prostate cancer: U.S. Preventative Services Task Force recommendation statement. Annals of Internal Medicine, 149(3), 185–191.

    Article  Google Scholar 

  • U.S. Preventative Services Task Force. (2009). Screening for breast cancer: U.S. Preventative Services Task Force recommendation statement. Annals of Internal Medicine, 151(10), 716–726.

    Article  Google Scholar 

  • van Dijck, J. A., Holland, R., Verbeek, A. L., Hendriks, J. H., & Mravunac, M. (1994). Efficacy of mammographic screening of the elderly: A case referent study in the Nijmegen program in The Netherlands. Journal of the National Cancer Institute, 86, 934–938.

    Article  Google Scholar 

  • Verdecchia, A., Francisci, S., Brenner, H., Gatta, G., Micheli, A., Mangone, L., & Kunkler, I. (2007). Recent cancer survival in Europe: A 2000–02 period analysis of EUROCARE-4 data. The Lancet Oncology, 8, 784–796.

    Article  Google Scholar 

  • von Karsa, L., Anttila, A., Ronco, G., Ponti, A., Malila, N., Arbyn, M., et al. (2008). Cancer Screening in the European Union: Report on the implementation of the Council Recommendation on cancer screening. Luxembourg: European Commission.

    Google Scholar 

  • Walter, S. D., & Stitt, L. W. (1987). Evaluating the survival of cancer cases detected by screening. Statistics in Medicine, 6, 885–900.

    Article  Google Scholar 

  • Ward, E. M., Thun, M. J., Hannan, L. M., & Jemal, A. (2006). Interpreting cancer trends. Annals of the New York Academy of Sciences, 1076, 29–53.

    Article  Google Scholar 

  • Warner, E., Hill, K., Causer, P., Plewes, D., Jong, R., Yaffe, M., et al. (2011). Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. Journal of Clinical Oncology, 29(13), 1664–1669.

    Article  Google Scholar 

  • Welch, G. H. (2009). Overdiagnosis and mammography screening. British Medical Journal, 339, b1425.

    Article  Google Scholar 

  • Welch, H. G., & Black, W. C. (2010). Overdiagnosis in cancer. Journal of the National Cancer Institute, 102(9), 605–613.

    Article  Google Scholar 

  • Whitlock, E. P., Lin, J. S., Liles, E., Beil, T. L., & Fu, R. (2008). Screening for colorectal cancer: A targeted, updated systematic review for the U.S. Preventative Services Task Force. Annals of Internal Medicine, 149, 638–658.

    Article  Google Scholar 

  • Wilt, T. J., MacDonald, R., Rutks, I., Shamliyan, T. A., Taylor, B. C., & Kane, R. L. (2008). Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Annals of Internal Medicine, 148(6), 435–448.

    Article  Google Scholar 

  • Wingo, P. A., Ries, L. A., Rosenberg, H. M., et al. (1998). Cancer incidence and mortality, 1973–1995: A report card for the U.S. Cancer, 82, 1197–1207.

    Google Scholar 

  • World Health Organization, mortality database. http://www.who.int/whosis/whosis/

  • Zackrisson, S., Andersson, I., Janzon, L., Manjer, J., & Garne, J. P. (2006). Rate of overdiagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: Follow-up study. British Medical Journal, 332, 689–692.

    Article  Google Scholar 

  • Zavoral, M., Suchanek, S., Zavada, Z., Dusek, L., Muzik, J., Seifert, B., & Fric, P. (2009). Colorectal cancer screening in Europe. World Journal of Gastroenterology, 15(47), 5907–5915.

    Article  Google Scholar 

Download references

Acknowledgments

This work was supported by grant T32AG0037 from the National Institute on Aging to the University of Southern California.

Author information

Authors and Affiliations

  1. Davis School of Gerontology, Andrus Gerontology Center, University of Southern California, Los Angeles, CA, USA

    Krista Garcia & Eileen M. Crimmins

Authors
  1. Krista Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eileen M. Crimmins
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Krista Garcia .

Editor information

Editors and Affiliations

  1. , Dept of Demography, University of Texas, San Antonio, West Cesar E. Chavez Boulevard 501, San Antonio, 78207, Texas, USA

    Nazrul Hoque

  2. , Arkansas Department of Health, Health Statistics Branch, West Markham Street, Slot 19 4815, Little Rock, 72205-3867, Arkansas, USA

    Mary A. McGehee

  3. , School of Public Health, The University of Texas, John Smith Drive, Suite 200 7411, San Antonio, 78229, Texas, USA

    Benjamin S. Bradshaw

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Garcia, K., Crimmins, E.M. (2013). Cancer Screening in the U.S. and Europe: Policies, Practices, and Trends in Cancer Incidence and Mortality. In: Hoque, N., McGehee, M., Bradshaw, B. (eds) Applied Demography and Public Health. Applied Demography Series, vol 3. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6140-7_9

Download citation

Publish with us

Policies and ethics

Search

Navigation